These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37315325)

  • 1. Use of CAPTURE to Identify Individuals Who May or May Not Require Treatment for Chronic Obstructive Pulmonary Disease.
    Li Y; Wen F; Ma Q; Chen R; Sun Y; Liu T; Gu C; Hu S; Song J; Compton C; Zheng J; Zhong N; Jones P
    Am J Respir Crit Care Med; 2023 Aug; 208(4):435-441. PubMed ID: 37315325
    [No Abstract]   [Full Text] [Related]  

  • 2. Can CAPTURE be used to identify undiagnosed patients with mild-to-moderate COPD likely to benefit from treatment?
    Leidy NK; Martinez FJ; Malley KG; Mannino DM; Han MK; Bacci ED; Brown RW; Houfek JF; Labaki WW; Make BJ; Meldrum CA; Quezada W; Rennard S; Thomashow B; Yawn BP
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1901-1912. PubMed ID: 29942123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Well Does CAPTURE Translate?: An Exploratory Analysis of a COPD Case-Finding Method for Spanish-Speaking Patients.
    Quezada WA; Whippo BA; Jellen PA; Leidy NK; Mannino DM; Kim KJ; Han MK; Houfek JF; Make B; Malley KG; Meldrum CA; Rennard SI; Yawn BP; Martinez FJ; Thomashow BM;
    Chest; 2017 Oct; 152(4):761-770. PubMed ID: 28414029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease.
    Martinez FJ; Mannino D; Leidy NK; Malley KG; Bacci ED; Barr RG; Bowler RP; Han MK; Houfek JF; Make B; Meldrum CA; Rennard S; Thomashow B; Walsh J; Yawn BP;
    Am J Respir Crit Care Med; 2017 Mar; 195(6):748-756. PubMed ID: 27783539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings.
    Martinez FJ; Han MK; Lopez C; Murray S; Mannino D; Anderson S; Brown R; Dolor R; Elder N; Joo M; Khan I; Knox LM; Meldrum C; Peters E; Spino C; Tapp H; Thomashow B; Zittleman L; Make B; Yawn BP;
    JAMA; 2023 Feb; 329(6):490-501. PubMed ID: 36786790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV
    Chai CS; Ng DL; Bt Mos S; Ibrahim MAB; Tan SB; Pang YK; Liam CK
    BMC Pulm Med; 2023 Apr; 23(1):150. PubMed ID: 37118725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
    Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
    Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
    Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ratio of FEV
    Fortis S; Comellas AP; Bhatt SP; Hoffman EA; Han MK; Bhakta NR; Paine R; Ronish B; Kanner RE; Dransfield M; Hoesterey D; Buhr RG; Barr RG; Dolezal B; Ortega VE; Drummond MB; Arjomandi M; Kaner RJ; Kim V; Curtis JL; Bowler RP; Martinez F; Labaki WW; Cooper CB; O'Neal WK; Criner G; Hansel NN; Krishnan JA; Woodruff P; Couper D; Tashkin D; Barjaktarevic I
    Chest; 2021 Jul; 160(1):94-103. PubMed ID: 33539837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.
    Mittal R; Chhabra SK
    COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Radicioni G; Ceppe A; Ford AA; Alexis NE; Barr RG; Bleecker ER; Christenson SA; Cooper CB; Han MK; Hansel NN; Hastie AT; Hoffman EA; Kanner RE; Martinez FJ; Ozkan E; Paine R; Woodruff PG; O'Neal WK; Boucher RC; Kesimer M
    Lancet Respir Med; 2021 Nov; 9(11):1241-1254. PubMed ID: 34058148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malnutrition, Airflow Limitation and Severe Emphysema are Risks for Exacerbation of Chronic Obstructive Pulmonary Disease in Japanese Subjects: A Retrospective Single-Center Study.
    Yamaya M; Usami O; Nakayama S; Tode N; Yamada A; Ito S; Omata F; Momma H; Funakubo M; Ichinose M
    Int J Chron Obstruct Pulmon Dis; 2020; 15():857-868. PubMed ID: 32368031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial.
    Slebos DJ; Shah PL; Herth FJF; Pison C; Schumann C; Hübner RH; Bonta PI; Kessler R; Gesierich W; Darwiche K; Lamprecht B; Perez T; Skowasch D; Deslee G; Marceau A; Sciurba FC; Gosens R; Hartman JE; Srikanthan K; Duller M; Valipour A;
    Am J Respir Crit Care Med; 2019 Dec; 200(12):1477-1486. PubMed ID: 31404499
    [No Abstract]   [Full Text] [Related]  

  • 14. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.
    Han MK; Muellerova H; Curran-Everett D; Dransfield MT; Washko GR; Regan EA; Bowler RP; Beaty TH; Hokanson JE; Lynch DA; Jones PW; Anzueto A; Martinez FJ; Crapo JD; Silverman EK; Make BJ
    Lancet Respir Med; 2013 Mar; 1(1):43-50. PubMed ID: 24321803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Previous Pulmonary Tuberculosis on Chronic Obstructive Pulmonary Disease: Baseline Results from a Prospective Cohort Study.
    Wang Y; Li Z; Li F
    Comb Chem High Throughput Screen; 2023; 26(1):93-102. PubMed ID: 35388750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
    Ni H; Htet A; Moe S
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mini Nutritional Assessment Short-Form predicts exacerbation frequency in patients with chronic obstructive pulmonary disease.
    Yoshikawa M; Fujita Y; Yamamoto Y; Yamauchi M; Tomoda K; Koyama N; Kimura H
    Respirology; 2014 Nov; 19(8):1198-203. PubMed ID: 25208631
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.